Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Evaluate the Safety and Efficacy of DISP-10 in Participants With Advanced Gastrointestinal Cancers

NCT07544589 is registered in ClinicalTrials.gov with Dispatch Biotherapeutics as lead sponsor.

NCT NCT07544589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07544589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Evaluate the Safety and Efficacy of DISP-10 in Participants With Advanced Gastrointestinal Cancers
Lead sponsor
Dispatch Biotherapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
April 13, 2026
Completion date
April 30, 2046
Enrollment
66 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract carcinoma, colorectal cancer, esophageal adenocarcinoma, gastric adenocarcinoma, gastroesophageal adenocarcinoma